|
1
|
Bruedigam C and Lane SW: Telomerase in
hematologic malignancies. Curr Opin Hematol. 23:346–353. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
de Lange T: Shelterin: The protein complex
that shapes and safeguards human telomeres. Genes Dev.
19:2100–2110. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
O'Sullivan RJ and Karlseder J: Telomeres:
Protecting chromosomes against genome instability. Nat Rev Mol Cell
Biol. 11:171–181. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Frescas D and de Lange T: A TIN2
dyskeratosis congenita mutation causes telomerase-independent
telomere shortening in mice. Genes Dev. 28:153–166. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Frescas D and de Lange T: Binding of TPP1
protein to TIN2 protein is required for POT1a,b protein-mediated
telomere protection. J Biol Chem. 289:24180–24187. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Abreu E, Aritonovska E, Reichenbach P,
Cristofari G, Culp B, Terns RM, Lingner J and Terns MP:
TIN2-tethered TPP1 recruits human telomerase to telomeres in vivo.
Mol Cell Biol. 30:2971–2982. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gramatges MM and Bertuch AA: Short
telomeres: From dyskeratosis congenita to sporadic aplastic anemia
and malignancy. Transl Res. 162:353–363. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Walne AJ, Vulliamy T, Beswick R, Kirwan M
and Dokal I: TINF2 mutations result in very short telomeres:
Analysis of a large cohort of patients with dyskeratosis congenita
and related bone marrow failure syndromes. Blood. 112:3594–3600.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bhanot M and Smith S: TIN2 stability is
regulated by the E3 Ligase Siah2. Mol Cell Biol. 32:376–384. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Frescas D and de Lange T: TRF2-tethered
TIN2 can mediated telomere protection by TPP1/POT1. Mol Cell Biol.
34:1349–1362. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gancarcíková M, Zemanová Z, Brezinová J,
Berková A, Vcelíková S, Smigová J and Michalová K: The role of
telomeres and telomerase complex in haematological neoplasia: The
length of telomeres as a marker of carcinogenesis and prognosis of
disease. Prague Med Rep. 111:91–105. 2010.PubMed/NCBI
|
|
12
|
Oh BK, Kim YJ, Park C and Park YN:
Up-regulation of telomere-binding proteins, TRF1, TRF2, and TIN2 is
related to telomere shortening during human multistep
hepatocarcinogenesis. Am J Pathol. 166:73–80. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim H, Yoo JE, Cho JY, Oh BK, Yoon YS, Han
HS, Lee HS, Jang JJ, Jeong SH, Kim JW and Park YN: Telomere length,
TERT and shelterin complex proteins in hepatocellular carcinomas
expressing ‘stemness’-related markers. J Hepatol. 59:746–752. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Miyachi K, Fujita M, Tanaka N, Sasaki K
and Sunagawa M: Correlation between telomerase activity and
telomeric-repeat binding factors in gastric cancer. J Exp Clin
Cancer Res. 21:269–275. 2002.PubMed/NCBI
|
|
15
|
Klapper W, Krams M, Qian W, Janssen D and
Parwaresch R: Telomerase activity in B-cell non-Hodgkin lymphomas
is regulated by hTERT transcription and correlated with
telomere-binding protein expression but uncoupled from
proliferation. Br J Cancer. 89:713–719. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Saito K, Yagihashi A, Nasu S, Izawa Y,
Nakamura M, Kobayashi D, Tsuji N and Watanabe N: Gene expression
for suppressors of telomerase activity (telomeric-repeat binding
factors) in breast cancer. Jpn J Cancer Res. 93:253–258. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yamada M, Tsuji N, Nakamura M, Moriai R,
Kobayashi D, Yagihashi A and Watanabe N: Down-regulation of TRF1,
TRF2 and TIN2 genes is important to maintain telomeric DNA for
gastric cancers. Anticancer Res. 22:3303–3307. 2002.PubMed/NCBI
|
|
18
|
Hu H, Zhang Y, Zou M, Yang S and Liang XQ:
Expression of TRF1, TRF2, TIN2, TERT, KU70, and BRCA1 proteins is
associated with telomere shortening and may contribute to
multistage carcinogenesis of gastric cancer. J Cancer Res Clin
Oncol. 136:1407–1414. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dai CH, Gan LN, Qin WU, Zi C, Zhu GQ, Wu
SL and Bao WB: Use of fluorescence quantitative polymerase Chain
reaction (PCR) for the dectetion of Escherichia coli adhesion to
pig intestinal epithelial cells. Pol J Vet Sci. 19:619–625.
2016.PubMed/NCBI
|
|
20
|
Kim SH, Davalos AR, Heo SJ, Rodier F, Zou
Y, Beausejour C, Kaminker P, Yannone SM and Campisi J: Telomere
dysfunction and cell survival: Roles for distinct TIN2-containing
complexes. J Cell Biol. 181:447–460. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shay JW: Role of telomeres and telomerase
in aging and cancer. Cancer Discov. 6:584–593. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Silva AG, Graves HA, Guffei A, Ricca TI,
Mortara RA, Jasiulionis MG and Mai S: Telomere-centromere-driven
genomic instability contributes to karyotype evolution in a mouse
model of melanoma. Neoplasia. 12:11–19. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hartmann K, Illing A, Leithäuser F,
Baisantry A, Quintanilla-Martinez L and Rudolph KL: Gene dosage
reductions of Trf1 and/or Tin2 induce telomere DNA damage and
lymphoma formation in aging mice. Leukemia. 30:749–753. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zou L: Single- and double-stranded DNA:
Building a trigger of ATR-mediated DNA damage response. Genes Dev.
21:879–885. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Augereau A, T'kint de Roodenbeke C,
Simonet T, Bauwens S, Horard B, Callanan M, Leroux D, Jallades L,
Salles G, Gilson E and Poncet D: Telomeric damage in early stage of
chronic lymphocytic leukemia correlates with shelterin
dysregulation. Blood. 118:1316–1322. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guièze R, Pages M, Véronèse L, Combes P,
Lemal R, Gay-Bellile M, Chauvet M, Callanan M, Kwiatkowski F,
Pereira B, et al: Telomere status in chronic lymphocytic leukemia
with TP53 disruption. Oncotarget. 7:56976–56985. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim SH, Kaminker P and Campisi J: TIN2, a
new regulator of telomere length in human cells. Nat Genet.
23:405–412. 1999. View
Article : Google Scholar : PubMed/NCBI
|
